Longtime Pfizer vet tapped to replace legendary vaccine researcher Kathrin Jansen
Kathrin Jansen, the legendary vaccine researcher who spearheaded Pfizer’s work on its historic Covid-19 shot, announced last month that she’s hanging up her lab coat. On Wednesday, the pharma giant revealed that it isn’t going far for her replacement.
Pfizer is tapping Annaliesa Anderson, known most recently for her work on the Covid-19 antiviral Paxlovid, to fill Jansen’s role as senior VP and head of vaccine R&D. Anderson most recently served as VP and CSO for bacterial research and hospital within the company’s vaccine R&D unit.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.